Early treatment with lenalidomide for smoldering multiple myeloma appeared to delay progression to symptomatic multiple myeloma compared with observation alone, according to results of a randomized phase 3 trial published in Journal of Clinical Oncology.“We decided to conduct this research after a 2013 trial by Mateos and colleagues of lenalidomide plus dexamethasone compared with
The human leukocyte antigen DRB1*01:03 allele was associated with severe ulcerative colitis, along with greater odds for major operation, hospitalization and corticosteroid use, according to…
The majority of adults with hypoparathyroidism achieved normal serum calcium levels with palopegteriparatide at 1 year without supplemental vitamin D or calcium, according to data…
Among younger women in the Middle East, those with overweight or obesity were more likely to have hypertension, diabetes and pregnancy-related issues than those without…
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with…
Among pregnancies in patients with systemic lupus erythematosus, those with small for gestational age infants were significantly more likely to demonstrate increased perivillous fibrin deposition…
BOSTON — People living in disadvantaged neighborhoods that see a high environmental burden or social vulnerability score experienced increased rates of asthma and COPD, according…
In September, Apple received marketing clearance from the FDA for its sleep apnea feature within the Health app on the Apple Watch Series 9, Series…
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Timothy L. Jackson, PhD, MBChB, discusses phase 2b trial results of sozinibercept for…
BOSTON — In a sample of 114 adults with bronchiectasis, 46.5% received a score that indicated impaired swallow function, according to a presentation at the…
Aquestive Therapeutics expects to finish its final supportive study of its Anaphylm sublingual epinephrine film for the treatment of anaphylaxis by the end of 2024.Epinephrine…
